Development of Therapies for Celiac Disease March 20-21, 2014
Host Celiac Disease Center at Columbia University, New York
A scientific program designed for those interested in the development of non-dietary therapies for celiac disease
Presentation Summaries in RED
Important issues Markku Maki - Finland (Moderator)
Screening in celiac disease in childhood, pros & cons Ivor Hill & Edwin Liu - USA
- Debated the use of screening asymptomatic but, at risk children for celiac disease no final conclusion.
Gluten and biopsy outcome, why is it important in drug trials? Markku Maki - Finland
- Currently, biopsy tissue preparation is a variable that impacts the reading and interpretation of the slides, thus impacting research results. Biopsy data is the prime criteria in determining the outcome in drug trials.
back to Development of Therapies